Antibody-engineered nanoparticles selectively inhibit mesenchymal cells isolated from patients with chronic lung allograft dysfunction. - Cova E; Colombo M; Inghilleri S; Morosini M; Miserere S; Peñaranda-Avila J; Santini B; Piloni D; Magni S; Gramatica F; Prosperi D; Meloni F (Nanomedicine (London, England), 2015)